Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Hughes (London, United Kingdom). Measurement of diffusion in pulmonary vascular disorders. Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases

Member's Comments

No comment yet.

Related content which might interest you: Changes of the recruitment characteristics of the pulmonary vascular bed in pulmonary hypertension measured by intra breath diffusion Source: Eur Respir J 2003; 22: Suppl. 45, 146s Year: 2003 Correction of endothelial dysfunction in patients with pulmonary diseases Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Pulmonary vascular diseases Source: ERS Course 2015 Year: 2015 Pulmonary vascular diseases Source: ERS Skills Course 2016 Year: 2016 The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations Source: Eur Respir Rev 2014; 23: 350-355 Year: 2014 Cardiac function in idiopathic pulmonary arterial hypertension patients with a severely reduced diffusion capacity Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Low DLCO in pulmonary vascular diseases Source: Virtual Congress 2021 – Pulmonary vascular diseases Year: 2021 Estimation of pulmonary vascular resistance by functional MRI Source: Annual Congress 2010 - Vascular and haemodynamics Year: 2010 Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 COVID-19 and the pulmonary circulation Source: ERS webinar 2020: COVID-19 and the pulmonary circulation Year: 2020 Updates in pulmonary hypertension and other pulmonary vascular diseases Source: Breathe, 15 (3) 241; 10.1183/20734735.0187-2019 Year: 2019 Mechanisms underlying pulmonary vascular changes in COPD patients Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019 Comparison of current therapies against endothelin-induced growth in pulmonary smooth arterial muscle cells (PASMCs) derived from patients with pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Pulmonary vascular and cardiac impairment in interstitial lung disease Source: Eur Respir Rev 2017; 26: 160128 Year: 2017 Measurement of lung diffusion in cardiovascular disease Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases Year: 2004 Smooth muscle microparticles as novel biomarkers of vascular remodelling and inflammation in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Association between diffusion capacity and endothelial function in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018 Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021 Year: 2021